SynthesisBrain and behavior2026
New Perspectives on the Efficacy of Governor Vessel Moxibustion Combined With Rehabilitation Training for Poststroke Muscle Spasticity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Synthesis in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New perspectives from evidence to action - patient-centered evidence transformation in evidence-based nursing: a narrative review.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMuscle spasticity, a prevalent motor impairment after stroke, substantially diminishes patients' quality of life. Governor Vessel moxibustion (GVM), a significant complementary therapy, shows promise, yet the current evidence remains inadequate. This study aimed to evaluate the efficacy of GVM with routine rehabilitation training in alleviating poststroke spasticity (PSS).
methodsWe searched PubMed, Cochrane Library, Embase, Web of Science, four Chinese databases, and clinical trials registry for randomized controlled trials (RCTs) of PSS patients who mainly received GVM treatment alongside conventional rehabilitation. Statistical evaluations were conducted using Review Manager 5.4 and R Studio. For assessing bias in the included studies, the Cochrane risk of bias tool (RoB 2.0) was used to evaluate RCTs.
resultsEleven studies involving 859 PSS patients were included. Meta-analysis demonstrated that when combined with routine rehabilitation training, GVM effectively alleviated muscle spasticity, as measured by the modified Ashworth scale (MD, -0.65 [95% CI, -0.84 to -0.47], p < 0.01) and the composite spasticity index (MD, -1.82 [95% CI, -2.25 to -1.39], p < 0.01). The treatment time and frequency could potentially be the main contributors to heterogeneity. Results suggested that a treatment regimen consisting of 60-min sessions conducted once-weekly and lasting for at least 8 weeks was the most effective, providing evidence for optimizing clinical application of GVM combined with rehabilitation training in PSS management.
conclusionGVM serves as an effective complementary therapy to routine rehabilitation for PSS patients, with generally mild adverse events. However, before formulating evidence-based and definitive recommendations, more rigorously designed and in-depth research is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.